$RXSF $3.33 MAJOR CATALYSTS COMING >> Research R
Post# of 225
Posted On: 01/19/2016 7:02:02 AM
$RXSF $3.33 MAJOR CATALYSTS COMING >>
Research Reports Projects $17.41 for Fiscal 2016 very Undervalued/Conservative
Here's the future of Fingerprint Technology and Medical Devices
$25,000,000 Investment Bank Financing 3 Phase Deal
CVS In store Deal Upwards $10m for All 7,800 Stores
National Commercials Release for RX DrugSafe
IP Acquisitions/Company Acquisitions/Mergers
OEMS Partnerships Valued $3m+ Per Month (Rx SafeDose), Thousands Available! (Infusion Pumps)
New Products Coming (12 Already)
New Board Members
Ultimately Up Listing To NASDAQ with Fiscal 2016 Projection of $17.41 Very Conservative
Rx Safe's Inc Can Generate Billions in Revenues, if Everything Falls into Place.
Insiders have Purchased Almost $50k in Stock Since Split. Officially Holding 70-80% Commons.
**280,000 Float, No Dilution**
Research Reports Projects $17.41 for Fiscal 2016 very Undervalued/Conservative
Here's the future of Fingerprint Technology and Medical Devices
$25,000,000 Investment Bank Financing 3 Phase Deal
CVS In store Deal Upwards $10m for All 7,800 Stores
National Commercials Release for RX DrugSafe
IP Acquisitions/Company Acquisitions/Mergers
OEMS Partnerships Valued $3m+ Per Month (Rx SafeDose), Thousands Available! (Infusion Pumps)
New Products Coming (12 Already)
New Board Members
Ultimately Up Listing To NASDAQ with Fiscal 2016 Projection of $17.41 Very Conservative
Rx Safe's Inc Can Generate Billions in Revenues, if Everything Falls into Place.
Insiders have Purchased Almost $50k in Stock Since Split. Officially Holding 70-80% Commons.
**280,000 Float, No Dilution**
(0)
(0)GeneSYS ID, Inc. (GNID) Stock Research Links
Scroll down for more posts ▼